BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dipasquale V, Passanisi S, Cucinotta U, Cascio A, Romano C. Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease. Ital J Pediatr 2021;47:71. [PMID: 33761992 DOI: 10.1186/s13052-021-01020-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Magalhães T, Granado MC, Manuel AR, Espinheira MDC, Trindade E. Impact of COVID-19 in Pediatric Patients and Young Adults with Inflammatory Bowel Disease. GE Port J Gastroenterol. [DOI: 10.1159/000522073] [Reference Citation Analysis]
2 Lombardo F, Salzano G, Bombaci B, Basile P, Lucania G, Alibrandi A, Passanisi S. Has COVID-19 lockdown improved glycaemic control in pediatric patients with type 1 diabetes? An analysis of continuous glucose monitoring metrics. Diabetes Res Clin Pract 2021;178:108988. [PMID: 34331977 DOI: 10.1016/j.diabres.2021.108988] [Reference Citation Analysis]
3 Brogna C, Brogna B, Bisaccia DR, Giuliano M, Montano L, Cristoni S, Petrillo M, Piscopo M. SARS-CoV-2: Reinfection after 18 Months of a Previous Case with Multiple Negative Nasopharyngeal Swab Tests and Positive Fecal Molecular Test. Medicina 2022;58:642. [DOI: 10.3390/medicina58050642] [Reference Citation Analysis]
4 Stepan MD, Cioboata R, Vintilescu ŞB, Vasile CM, Osman A, Ciolofan MS, Popescu M, Petrovici IL, Zavate AC. Pediatric Functional Abdominal Pain Disorders following COVID-19. Life 2022;12:509. [DOI: 10.3390/life12040509] [Reference Citation Analysis]